Skip to main content
Log in

Graves’ disease after percutaneous ethanol injection for the treatment of autonomous thyroid adenoma

  • Letter to the Editor
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Monzani F., Del Guerra P., Caraccio N., Casolaro A., Lippolis P.V., Goletti O. Appearance of Graves’ disease after percutaneous ethanol injection for the treatment of hyperfunctioning thyroid adenoma. J. Endocrinol. Invest: 20: 294, 1997.

    Article  PubMed  CAS  Google Scholar 

  2. Chiovato L., Santini F., Vitti P., Bendinelli G., Pinchera A. Appearance of thyroid stimulating antibody and Graves’ disease after radioiodine therapy for toxic nodule. Clin. Endocrinol. (Oxf) 40: 803, 1994.

    Article  CAS  Google Scholar 

  3. Nygaard B., Faber J., Veje A., Hegedus L., Hansen J.M. Appearance of Graves’ like disease after radioiodine therapy for toxic as well non-toxic multinodular goitre. Clin. Endocrinol. (Oxf) 43: 129, 1995.

    Article  CAS  Google Scholar 

  4. Bendezu R., Wieland G., Tang P., Levine B. Unusual events preceding hyperthyroidism with diffuse goiter. Arch. Intern. Med. 137: 1023, 1977.

    Article  PubMed  CAS  Google Scholar 

  5. Smyth P.P.A., Neylan D., MacMullan N.M., Smith D.F., McKenn T.J. Sequential presentation of a case of hyperthyroidism with autonomously functioning nodules and Graves’ disease in the presence of IgG thyroid stimulators. Acta Endocrinol. (Copenh.) 118: 474, 1988.

    CAS  Google Scholar 

  6. Nygaard B., Knudsen J.H., Hegedus L., Veje Cand Scient A., Hansen J.E.M. Thyrotropin receptor antibodies and Graves’ disease, a side-effect of 131I treatment in patients with non-toxic goiter. J. Clin. Endocrinol. Metab. 82: 2926, 1997.

    PubMed  CAS  Google Scholar 

  7. Charkes N. D. Graves’ disease with functioning nodules (Marine-Lenhart syndrome). J. Nucl. Med. 13: 885, 1972.

    PubMed  CAS  Google Scholar 

  8. Vitti P., Rago T., Mancusi F., Pallini S., Tonacchera M., Santini F., Chiovato L., Marcocci C., Pinchera A. Thyroid hypoechogenic pattern at ultrasonography as a tool for predicting recurrence of hyperthyroidism after medical treatment in patients with Graves’ disease. Acta Endocrinol. 126: 128, 1992.

    PubMed  CAS  Google Scholar 

  9. Lippi F., Ferrari C., Manetti L., Rago T., Santini F., Monzani F., Bellitti P., Papini E., Busnardo B., Angelini P., Pinchera A., and The Multicenter Study Group. Treatment of solitary autonomous thyroid nodules by percutaneous ethanol injection: results of an Italian Multicenter Study. J. Clin. Endocrinol. Metab. 81: 3261, 1996.

    PubMed  CAS  Google Scholar 

  10. Papini E., Pacella C.M., Verde G. Percutaneous ethanol injection (PEI): what is its role in the treatment of benign thyroid nodules? Thyroid 5: 147, 1995.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Verde, G. Graves’ disease after percutaneous ethanol injection for the treatment of autonomous thyroid adenoma. J Endocrinol Invest 21, 334–335 (1998). https://doi.org/10.1007/BF03350338

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03350338

Keywords

Navigation